MD
Mednax Inc
NYSE: MD · HEALTHCARE · MEDICAL CARE FACILITIES
$23.37
+1.07% today
Updated 2026-06-05
Market cap
$2.00B
P/E ratio
11.80
P/S ratio
1.03x
EPS (TTM)
$2.06
Dividend yield
—
52W range
$12 – $25
Volume
0.8M
WallStSmart proprietary scores
66
out of 100
Grade: B
Buy
Investment rating
5.3
Growth
C+5.5
Quality
C+6.5
Profitability
B10.0
Valuation
A+5/9
Piotroski F-Score
Moderate
1.7
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →199 stocks currently score above 75
Price targets
Analyst target
$23.17
-0.86%
12-Month target
$23.60
+0.98%
Intrinsic (DCF)
$61.27
Margin of safety
+64.96%
0 Strong Buy2 Buy5 Hold0 Sell0 Strong Sell
Price chart
Stock snapshot
Strengths
+ 64.96% below intrinsic value
Risks
- Altman Z 1.71 — distress zone
- Negative free cash flow $-135.75M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $1.97B | $1.99B | $2.01B | $1.91B | $1.93B |
| Net income | $66.33M | $-60.41M | $-99.07M | $165.39M | $29.57M |
| EPS | — | — | — | — | $2.06 |
| Free cash flow | $137.23M | $104.00M | $184.55M | $252.63M | $-135.75M |
| Profit margin | 3.36% | -3.03% | -4.92% | 8.64% | 9.02% |
Peer comparison
Smart narrative
Mednax Inc trades at $23.37. representing a P/E of 11.80x trailing earnings. Our Smart Value Score of 66/100 indicates the stock is good. The company scores 5/9 on the Piotroski F-Score. With an Altman Z-Score of 1.71, it sits in the distress. TTM revenue stands at $1.93B. with profit margins at 9.02%. Our DCF model estimates intrinsic value at $61.27.
Frequently asked questions
What is Mednax Inc's stock price?
Mednax Inc (MD) trades at $23.37, on a P/E of 11.8x and a P/S of 1.0x. Those multiples show what the market is paying for each dollar of earnings and sales, which is the real starting point for judging whether the price is reasonable.
Is Mednax Inc overvalued?
Mednax Inc carries a Smart Value Score of 66/100 (Grade B), which we rate Buy. That score blends growth, quality, and valuation into one read. Our DCF puts intrinsic value at $61.27 versus the $23.37 price, a 65.0% margin of safety on a cash flow basis.
What is the price target of Mednax Inc (MD)?
The 12-month analyst consensus target is $23.17, about 0.9% below the current $23.37. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.
What is the intrinsic value of Mednax Inc (MD)?
Our DCF model estimates intrinsic value at $61.27, a +65.0% margin of safety versus today's $23.37. Intrinsic value is what the projected cash flows are worth today. A positive reading means the price sits below that estimate, leaving a cushion if growth holds.
What is Mednax Inc's revenue?
Mednax Inc's trailing twelve-month revenue is $1.93B. Revenue scale anchors the valuation multiples and shows whether growth is reaching the top line, so it is best read alongside margin and growth trends to see if that revenue is getting more profitable over time.
Altman Z-Score?
Mednax Inc's Altman Z-Score is 1.71, which places it in the distress. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.
Company info
SectorHEALTHCARE
IndustryMEDICAL CARE FACILITIES
CountryUSA
ExchangeNYSE
CurrencyUSD
Quick metrics
P/S ratio1.03x
ROE19.83%
Beta0.70
50D MA$22.48
200D MA$20.63
Shares out0.08B
Float0.08B
Short ratio—
Avg volume0.8M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—